| 產(chǎn)品名稱(chēng) |
Proteus mirabilis Hauser |
| 商品貨號(hào) |
B235953 |
| Strain Designations |
2573 |
| Isolation |
Patient with struvite urinary calculus |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties |
Serotype O:6 |
| Product Format |
frozen |
| Storage Conditions |
-80°C or colder |
| Preceptrol® |
no |
| Type Strain |
no |
| Comments |
Capsule structure, serotype O:6 |
| Medium |
ATCC® Medium 18: Trypticase Soy Agar/Broth
|
| Growth Conditions |
Temperature: 37.0°C
Atmosphere: Aerobic |
| Name of Depositor |
RJ McLean |
| References |
Beynon LM, et al. Capsule structure of Proteus mirabilis (ATCC 49565). J. Bacteriol. 174: 2172-2177, 1992. PubMed: 1551839
|
